To test the possibility that DNASE1L3 may function as a tumor suppressor, we decided to leverage a previously generated full-body constitutive Dnase1l3-deficient (KO) mouse strain (19) in several models of CRC. Here, DNASE1L3 is linked to colorectal carcinoma.